RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.
When PET radiotracers are introduced into the body, cancer absorbs them and acts as a biological beacon, which our machine can use to track and treat cancer in real time.
Learn More About Emissions
Our technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.
Learn About Targeting
Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session.
Discover the Potential
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.
Learn About Treatment
By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.
Discover RefleXion Therapy.
See how RefleXion Therapy can play a role
in your cancer program.
HAYWARD, Calif., Jan. 20, 2020 – RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced the appointment of Jeff Holifield, J.D. as vice president and head of legal effective immediately. Holifield will report directly to President and Chief Executive Officer, Todd Powell. […]
Please click on the PDF button below to read the complete article:
In our first of two final blog posts of 2020, we shared reflections from our RefleXion family. The end of 2020 looks vastly different than it did at the beginning. And while COVID-19 continues to spread, and the need for face masks, social distancing and handwashing continues, there are now viable vaccines expected to be […]
Let us tell you more.
Contact UsStay up to date.
Sign Up|
|